Results 241 to 250 of about 6,128,992 (338)

Strengthening Faculty Development at Tribal Colleges and Universities: A Critical Review and Three‐Tiered Framework

New Directions for Community Colleges, EarlyView.
ABSTRACT Tribal Colleges and Universities (TCUs) play a critical role in Indigenous nation‐building and postsecondary access, yet faculty development within these institutions remains chronically under‐resourced and inconsistently supported. This critical literature review examines faculty development across TCUs that function primarily within the ...
Karen Colbert, Shaina Nez, Sarah Vande Corput, Stephen Wall   +3 more
wiley   +1 more source

Epistemicide, health systems, and planetary health: Re-centering Indigenous knowledge systems. [PDF]

PLOS Glob Public Health
Redvers N, Lokugamage AU, Barreto JPL, Bajracharya MB, Harris M.   +4 more
europepmc   +1 more source

Review of recent advances in the design, synthesis, and modification of biochar for remediation of heavy metal pollution in water

The Canadian Journal of Chemical Engineering, EarlyView.
Research frontiers in using biochar for heavy metal remediation. Abstract Heavy metal contamination of water has long been a serious environmental issue. Biochar and biochar‐based composites are emerging as effective and sustainable solutions for heavy metal removal due to their strong adsorption abilities and environmentally friendly nature.
Soumik Chakma, Mehedi Hasan, Sudip K. Rakshit, Janusz Kozinski, Kang Kang   +4 more
wiley   +1 more source

Indigenous knowledge for conservation

Nature Sustainability, 2019
V. Reyes‐García, Petra Benyei
semanticscholar   +1 more source

Ethnobotanical and Nutritional Evaluation of Understudied Wild Edible Fruits in South Africa: Bridging Indigenous Knowledge and Food Security: A Review. [PDF]

Foods
Lubisi NP, Matlala ME, Ramarumo LJ, Ndhlovu PT.   +3 more
europepmc   +1 more source

Lower Dose‐Normalized Tacrolimus Exposure in CYP3A5*6 vs. *3 Loss‐of‐Function Allele Carriers: A Longitudinal Retrospective Real‐World Study in Kidney Transplant Recipients

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacogenomic research has historically focused on individuals of European ancestry, leading to the underrepresentation of genetic variants common in non‐European populations. This bias is exemplified by CYP3A5*6, a functionally consequential variant common in individuals of African ancestry (MAF: 11–19%) but virtually absent in Europeans (MAF: 0.15%)
Amar D. Levens, Dirk Jan A. R. Moes, Yanick Boer, Aiko P. J. de Vries, Dorottya K. de Vries, Danny van der Helm, Soufian Meziyerh, Dave L. Roelen, Stefan Böhringer, Teun Van Gelder, Jesse J. Swen   +10 more
wiley   +1 more source

Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations

Clinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder is a highly prevalent psychological disorder worldwide and its main treatment is the use of Selective Serotonin Reuptake Inhibitors. However, few studies have demonstrated the relationship between the presence of genetic variants in pharmacogenes and the efficacy of these drugs, especially in populations with a unique genetic ...
Kaio Evandro Cardoso Aguiar, Natasha Monte da Silva, Juliana Carla Gomes Rodrigues, André Maurício Ribeiro‐dos‐Santos, Sandro José de Souza, Ândrea Ribeiro‐dos‐Santos, João Farias Guerreiro, Sidney Emanuel Batista dos Santos, Marianne Rodrigues Fernandes, Ney Pereira Carneiro dos Santos   +9 more
wiley   +1 more source

Indigenous Knowledge and Education in Africa

Frontiers in African Business Research, 2019
Chika Ezeanya-Esiobu
semanticscholar   +1 more source

Exploring indigenous knowledge and practices of the Gurage community on the biosystematics and utilization of Enset landraces for bone fracture and regeneration: the case of Gurage Zone, central Ethiopia region. [PDF]

Front Pharmacol
Negassa T, Meressa A, Abdissa N, Degu S, Addis G, Debebe E, Abdisa N, W/Kidan S, Belitibo DB, Ashenef S, Shanko W, Zuber Z, Kumsa L, Kassahun M, Assamo FT, Endale M.   +15 more
europepmc   +1 more source

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients

Clinical Pharmacology &Therapeutics, EarlyView.
In Ontario, biologics have historically represented a small proportion of public drug claims but a large proportion of spending. Biosimilars, lower cost alternatives to biologics, offer a potential solution to the rising spending on biologics. From March 2023 to January 2024, the Ontario Ministry of Health required public drug program beneficiaries on ...
Anita Iacono, Martin K. H. Ho, Joanna Yang, Tonya Campbell, William Wynne, Dana Shearer, Lene Andersen, Eric Majer, Shaleesa Ledlie, Mina Tadrous, Tara Gomes   +10 more
wiley   +1 more source